Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Stopped The AAVCAGsCD59 asset has been transferred to Janssen Research and Development LLC

Conditions

• Dry Age-related Macular Degeneration
• Geographic Atrophy
• Gene Therapy
• Intravitreal Injection

Interventions

• BIOLOGICAL: Intravitreal AAVCAGsCD59
• OTHER: Intravitreal Sham Injection

Sponsor

Hemera Biosciences